论文部分内容阅读
视网膜色素变性(RP)和老年黄斑病变(AMD)是致盲的两个重要病因。视网膜修复技术通过在视网膜下或视网膜外植入微电子芯片或微电极阵列来刺激残留的功能正常的内层细胞而产生光影,从而恢复患者的部分视觉。人工视网膜芯片技术已成为视觉功能修复领域的研究热点,随着研究的深入,其临床应用仍有许多问题亟待解决。本文简介了人工视网膜技术的原理和各国的研究现状,深入探讨了影响视网膜技术临床应用的关键问题,并提出了部分意见和建议。
Retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are two important causes of blinding. Retinal repair technology through the subretinal or retinal microelectrode chip or microelectrode array implantation to stimulate the function of normal residual residual inner cells to produce light and shadow, so as to restore the patient’s partial vision. Artificial retina chip technology has become a hot research field in the field of visual function repair. With the further research, there are still many problems to be solved in clinical application. This article briefly introduces the principle of artificial retina technology and the current research situation in various countries. It probes into the key issues that affect the clinical application of retinal technology and puts forward some suggestions and suggestions.